logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
12/09/2025
Microsoft and OpenAI announced on Thursday that they have signed a non-binding agreement on new terms for their relationship. This agreement will allow OpenAI to advance its restructuring plan to become a for-profit company.
Latest
1 m ago
The Nikkei futures index rose 0.88% in early trading in Japan.
2 m ago
Turning point is approaching, new forces in car manufacturing are making a profit sprint.
3 m ago
Securities Times: Expectations for the central bank to restart government bond trading operations are rising, with the timing potentially in the fourth quarter.
3 m ago
Ka Li Pharmaceutical: Controlling shareholders make a voluntary commitment to a sales ban.
3 m ago
Galecto Biotech announced on the Hong Kong Stock Exchange that the Board of Directors hereby announces that Dr. Hans Schambye (founder of Galecto, Chairman and CEO of the Board, and major shareholder of the Company) and Ms. Hoi Ching To (Executive Director and major shareholder of the Company, spouse of Dr. Schambye) have voluntarily committed not to sell (including but not limited to selling or pledging) any shares of the Company held by them or controlled by them directly or indirectly, until the release of the following three clinical data, in order to express their firm confidence in the Company's long-term value and future prospects.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.